{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:11:12Z","timestamp":1789985472002,"version":"4.0.1"},"reference-count":28,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2019,3,1]]},"DOI":"10.1248\/bpb.b18-00928","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T17:33:32Z","timestamp":1547055212000},"page":"489-495","source":"Crossref","is-referenced-by-count":14,"title":["Curcumin Down-Regulates Toll-Like Receptor-2 Gene Expression and Function in Human Cystic Fibrosis Bronchial Epithelial Cells"],"prefix":"10.1248","volume":"42","author":[{"given":"Niraj","family":"Chaudhary","sequence":"first","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"},{"name":"Program for Leading Graduate School of \u201cHIGO (Health Life Science: Interdisciplinary and Global Oriented) Program,\u201d Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Ueno-Shuto","sequence":"additional","affiliation":[{"name":"Laboratory of Pharmacology, Division of Life Science, Faculty of Pharmaceutical Sciences, Sojo University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Ono","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Ohira","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Institute of Gene Research, Yamaguchi University Science Research Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoi","family":"Nasu","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruka","family":"Fujikawa","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"},{"name":"Program for Leading Graduate School of \u201cHIGO (Health Life Science: Interdisciplinary and Global Oriented) Program,\u201d Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryunosuke","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriki","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Suico","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Kai","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Shuto","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Elborn JS. Cystic fibrosis. <i>Lancet<\/i>, <b>388<\/b>, 2519\u20132531 (2016).","DOI":"10.1016\/S0140-6736(16)00576-6"},{"key":"2","unstructured":"2) Haq IJ, Gray MA, Garnett JP, Ward C, Brodlie M. Airway surface liquid homeostasis in cystic fibrosis: Pathophysiology and therapeutic targets. <i>Thorax<\/i>, <b>71<\/b>, 284\u2013287 (2016)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Muir A, Soong G, Sokol S, Reddy B, Gomez MI, Van Heeckeren A, Prince A. Toll-like receptors in normal and cystic fibrosis airway epithelial cells. <i>Am. J. Respir. Cell Mol. Biol.<\/i>, <b>30<\/b>, 777\u2013783 (2004).","DOI":"10.1165\/rcmb.2003-0329OC"},{"key":"4","unstructured":"4) Firoved AM, Ornatowski W, Deretic V. Microarray analysis reveals induction of lipoprotein genes in mucoid <i>Pseudomonas aeruginosa<\/i>: implications for inflammation in cystic fibrosis. <i>Infect. Immun.<\/i>, <b>72<\/b>, 5012\u20135018 (2004)."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shuto T, Furuta T, Oba M, Xu H, Li J-D, Cheung J, Gruenert DC, Uehara A, Suico MA, Okiyoneda T, Kai H. Promoter hypomethylation of Toll-like receptor-2 gene is associated with increased proinflammatory response toward bacterial peptidoglycan in cystic fibrosis bronchial epithelial cells. <i>FASEB J.<\/i>, <b>20<\/b>, 782\u2013784 (2006).","DOI":"10.1096\/fj.05-4934fje"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Furuta T, Shuto T, Shimasaki S, Ohira Y, Suico MA, Gruenert DC, Kai H. DNA demethylation-dependent enhancement of toll-like receptor-2 gene expression in cystic fibrosis epithelial cells involves SP1-activated transcription. <i>BMC Mol. Biol.<\/i>, <b>9<\/b>, 39 (2008).","DOI":"10.1186\/1471-2199-9-39"},{"key":"7","unstructured":"7) Abdollahi E, Momtazi AA, Johnston TP, Sahebkar A. Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: a nature-made jack-of-all-trades? <i>J. Cell. Physiol.<\/i>, <b>233<\/b>, 830\u2013848 (2018)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Shuto T, Ono T, Ohira Y, Shimasaki S, Mizunoe S, Watanabe K, Suico MA, Koga T, Sato T, Morino S, Sato K, Kai H. Curcumin decreases toll-like receptor-2 gene expression and function in human monocytes and neutrophils. <i>Biochem. Biophys. Res. Commun.<\/i>, <b>398<\/b>, 647\u2013652 (2010).","DOI":"10.1016\/j.bbrc.2010.06.126"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Tu CT, Han B, Yao QY, Zhang YA, Liu HC, Zhang SC. Curcumin attenuates Concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4 and TLR9 expression. <i>Int. Immunopharmacol.<\/i>, <b>12<\/b>, 151\u2013157 (2012).","DOI":"10.1016\/j.intimp.2011.11.005"},{"key":"10","unstructured":"10) Kim YS, Kwon JS, Cho YK, Jeong MH, Cho JG, Park JC, Kang JC, Ahn Y. Curcumin reduces the cardiac ischemia-reperfusion injury: involvement of the toll-like receptor 2 in cardiomyocytes. <i>J. Nutr. Biochem.<\/i>, <b>23<\/b>, 1514\u20131523 (2012)."},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Cozens AL, Yezzi MJ, Kunzelmann K, Ohrui T, Chin L, Eng K, Finkbeiner WE, Widdicombe JH, Gruenert DC. CFTR expression and chloride secretion in polarized immortal human bronchial epithelial cells. <i>Am. J. Respir. Cell Mol. Biol.<\/i>, <b>10<\/b>, 38\u201347 (1994).","DOI":"10.1165\/ajrcmb.10.1.7507342"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Kamei S, Fujikawa H, Nohara H, Ueno-Shuto K, Maruta K, Nakashima R, Kawakami T, Matsumoto C, Sakaguchi Y, Ono T, Suico MA, Boucher RC, Gruenert DC, Takeo T, Nakagata N, Li JD, Kai H, Shuto T. Zinc deficiency <i>via<\/i> a splice switch in zinc importer ZIP2\/SLC39A2 causes cystic fibrosis-associated MUC5AC hypersecretion in airway epithelial cells. <i>EBioMedicine<\/i>, <b>27<\/b>, 304\u2013316 (2017).","DOI":"10.1016\/j.ebiom.2017.12.025"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Ueno-Shuto K, Kato K, Tasaki Y, Sato M, Sato K, Uchida Y, Sakai H, Ono T, Suico MA, Mitsutake K, Tokutomi N, Kai H, Shuto T. Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1 (Sp1) <i>via<\/i> the toll-like receptor 4 (TLR4)-p38 pathway in monocytes and neutrophils. <i>J. Biol. Chem.<\/i>, <b>289<\/b>, 18097\u201318109 (2014).","DOI":"10.1074\/jbc.M113.532093"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Jutooru I, Chadalapaka G, Lei P, Safe S. Inhibition of NF\u03baB and pancreatic cancer cell and tumor growth by curcumin is dependent on specificity protein down-regulation. <i>J. Biol. Chem.<\/i>, <b>285<\/b>, 25332\u201325344 (2010).","DOI":"10.1074\/jbc.M109.095240"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16) Hsin IL, Sheu GT, Chen HH, Chiu LY, Wang HD, Chan HW, Hsu CP, Ko JL. N-acetyl cysteine mitigates curcumin-mediated telomerase inhibition through rescuing of Sp1 reduction in A549 cells. <i>Mutat. Res. -<\/i>. <i>Fundam. Mol. Mech. Mutagen.<\/i>, <b>688<\/b>, 72\u201377 (2010).","DOI":"10.1016\/j.mrfmmm.2010.03.011"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17) Chadalapaka G, Jutooru I, Chintharlapalli S, Papineni S, Smith R 3rd, Li X, Safe S. Curcumin decreases specificity protein expression in bladder cancer cells. <i>Cancer Res.<\/i>, <b>68<\/b>, 5345\u20135354 (2008).","DOI":"10.1158\/0008-5472.CAN-07-6805"},{"key":"17","doi-asserted-by":"crossref","unstructured":"18) Ali A, Banerjea AC. Curcumin inhibits HIV-1 by promoting Tat protein degradation. <i>Sci. Rep.<\/i>, <b>6<\/b>, 27539 (2016).","DOI":"10.1038\/srep27539"},{"key":"18","doi-asserted-by":"crossref","unstructured":"19) Pongrakhananon V, Nimmannit U, Luanpitpong S, Rojanasakul Y, Chanvorachote P. Curcumin sensitizes non-small cell lung cancer cell anoikis through reactive oxygen species-mediated Bcl-2 downregulation. <i>Apoptosis<\/i>, <b>15<\/b>, 574\u2013585 (2010).","DOI":"10.1007\/s10495-010-0461-4"},{"key":"19","doi-asserted-by":"crossref","unstructured":"20) Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S, Sethi G. Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. <i>Biochem. Pharmacol.<\/i>, <b>73<\/b>, 1024\u20131032 (2007).","DOI":"10.1016\/j.bcp.2006.12.010"},{"key":"20","unstructured":"21) Kirschning CJ, Schumann RR. TLR2: cellular sensor for microbial and endogenous molecular patterns. <i>Curr. Top. Microbiol. Immunol.<\/i>, <b>270<\/b>, 121\u2013144 (2002)."},{"key":"21","doi-asserted-by":"crossref","unstructured":"22) Shuto T, Furuta T, Cheung J, Gruenert DC, Ohira Y, Shimasaki S, Suico MA, Sato K, Kai H. Increased responsiveness to TLR2 and TLR4 ligands during dimethylsulfoxide-induced neutrophil-like differentiation of HL-60 myeloid leukemia cells. <i>Leuk. Res.<\/i>, <b>31<\/b>, 1721\u20131728 (2007).","DOI":"10.1016\/j.leukres.2007.06.011"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23) Xu Y, Clark JC, Aronow BJ, Dey CR, Liu C, Wooldridge JL, Whitsett JA. Transcriptional adaptation to cystic fibrosis transmembrane conductance regulator deficiency. <i>J. Biol. Chem.<\/i>, <b>278<\/b>, 7674\u20137682 (2003).","DOI":"10.1074\/jbc.M210277200"},{"key":"23","doi-asserted-by":"crossref","unstructured":"24) Ogilvie V, Passmore M, Hyndman L, Jones L, Stevenson B, Wilson A, Davidson H, Kitchen RR, Gray RD, Shah P, Alton EW, Davies JC, Porteous DJ, Boyd AC. Differential global gene expression in cystic fibrosis nasal and bronchial epithelium. <i>Genomics<\/i>, <b>98<\/b>, 327\u2013336 (2011).","DOI":"10.1016\/j.ygeno.2011.06.008"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25) Clarke LA, Botelho HM, Sousa L, Falcao AO, Amaral MD. Transcriptome meta-analysis reveals common differential and global gene expression profiles in cystic fibrosis and other respiratory disorders and identifies CFTR regulators. <i>Genomics<\/i>, <b>106<\/b>, 268\u2013277 (2015).","DOI":"10.1016\/j.ygeno.2015.07.005"},{"key":"25","unstructured":"26) Kang J, Chen J, Shi Y, Jia J, Zhang Y. Curcumin-induced histone hypoacetylation: The role of reactive oxygen species. <i>Biochem. Pharmacol.<\/i>, <b>69<\/b>, 1205\u20131213 (2005)."},{"key":"26","doi-asserted-by":"crossref","unstructured":"27) Kim MS, Kang HJ, Moon A. Inhibition of invasion and induction of apoptosis by curcumin in H-ras-transformed MCF10A human breast epithelial cells. <i>Arch. Pharm. Res.<\/i>, <b>24<\/b>, 349\u2013354 (2001).","DOI":"10.1007\/BF02975105"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28) Guan F, Ding Y, Zhang Y, Zhou Y, Li M, Wang C. Curcumin suppresses proliferation and migration of MDA-MB-231 breast cancer cells through autophagy-dependent Akt degradation. <i>PLOS ONE<\/i>, <b>11<\/b>, e0146553 (2016).","DOI":"10.1371\/journal.pone.0146553"},{"key":"28","doi-asserted-by":"crossref","unstructured":"29) Di Martino P, Censi R, Gigliobianco MR, Zerrillo L, Magnoni F, Agas D, Quaglia W, Lupidi G. Nano-medicine improving the bioavailability of small molecules for the prevention of neurodegenerative diseases. <i>Curr. Pharm. Des.<\/i>, <b>23<\/b>, 1897\u20131908 (2017).","DOI":"10.2174\/1381612822666161227154447"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/3\/42_b18-00928\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T18:23:48Z","timestamp":1573669428000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/42\/3\/42_b18-00928\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b18-00928","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]}}}